Erratum to: “Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress” [Biochim. Biophys. Acta. 1832(6) 2013 Jun; 848–63. doi:10.1016/j.bbadis.2013.02.023. Epub 2013 Mar 6.PMID: 23474308] (Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) 1832(6) (848–863), (S0925443913000689), (10.1016/j.bbadis.2013.02.023));Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 6, 2013, Pages 848-863

  Dong, Maolong ^a,b   Hu, Nan ^b   Hua, Yinan ^b   Xu, Xihui ^b   Kandadi, Machender R ^b   Guo, Rui ^b   Jiang, Shasha ^b   Nair, Sreejayan ^b   Hu, Dahai ^a   Ren, Jun ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

Akt; Apoptosis; Contractile function; ER stress; Heart; Sepsis

Indexed keywords

AUTOPHAGY PROTEIN 7; BECLIN 1; CALCIUM ION; CASPASE 3; CASPASE 9; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOGEN SYNTHASE KINASE 3BETA; INITIATION FACTOR 2ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATASE; POLYUBIQUITIN; PROTEIN; PROTEIN BCL 2; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN P62; REACTIVE OXYGEN METABOLITE; SEQUESTOSOME 1; TENSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CALCIUM CELL LEVEL; CELL CYCLE ARREST; CELL GROWTH; DISEASE MARKER; DNA DAMAGE; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; EUKARYOTE; HEART DISEASE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 84875765138     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2022.166567     Document Type: Erratum

References (78)

1. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., Freivogel K., Weiss Y.G., Benbenishty J., Kalenka A., Forst H., Laterre P.F., Reinhart K., Cuthbertson B.H., Payen D., Briegel J. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 2008, 358:111-124.
2. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am. J. Respir. Crit. Care Med. 2003, 168:165-172.
3. Fernandes C.J., de Assuncao M.S. Myocardial dysfunction in sepsis: a large, unsolved puzzle. Crit. Care Res. Pract. 2012, 2012:896430.
4. Parrillo J.E. The cardiovascular pathophysiology of sepsis. Annu. Rev. Med. 1989, 40:469-485.
5. Niederbichler A.D., Westfall M.V., Su G.L., Donnerberg J., Usman A., Vogt P.M., Ipaktchi K.R., Arbabi S., Wang S.C., Hemmila M.R. Cardiomyocyte function after burn injury and lipopolysaccharide exposure: single-cell contraction analysis and cytokine secretion profile. Shock 2006, 25:176-183.
6. Vieillard-Baron A., Caille V., Charron C., Belliard G., Page B., Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit. Care Med. 2008, 36:1701-1706.
7. Neviere R.R., Cepinskas G., Madorin W.S., Hoque N., Karmazyn M., Sibbald W.J., Kvietys P.R. LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes. Am. J. Physiol. Heart Circ. Physiol. 1999, 277:H885-H892.
8. Ren J., Wu S. A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction?. Front. Biosci. 2006, 11:15-22.
9. Cowan D.B., Noria S., Stamm C., Garcia L.M., Poutias D.N., del Nido P.J., McGowan F.X. Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes. Circ. Res. 2001, 88:491-498.
10. Gupta A., Sharma A.C. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia. Shock 2003, 20:375-381.
11. Ren J. Wide spectrum of presentation and variable mechanisms of compromised cardiac function in multiple organ dysfunction syndrome. J. Organ Dysfunct. 2008, 4:239-248.
12. Manukyan M.C., Weil B.R., Wang Y., Abarbanell A.M., Herrmann J.L., Poynter J.A., Meldrum D.R. The phosphoinositide-3 kinase survival signaling mechanism in sepsis. Shock 2010, 34:442-449.
13. Zhang Y., Ren J. Thapsigargin triggers cardiac contractile dysfunction via NADPH oxidase-mediated mitochondrial dysfunction: role of Akt dephosphorylation. Free Radic. Biol. Med. 2011, 51:2172-2184.
14. Zhang Y., Xia Z., La Cour K.H., Ren J. Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeation pore opening. Antioxid. Redox Signal. 2011, 15:2407-2424.
15. Dugo L., Collin M., Allen D.A., Patel N.S., Bauer I., Mervaala E.M., Louhelainen M., Foster S.J., Yaqoob M.M., Thiemermann C. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat. Crit. Care Med. 2005, 33:1903-1912.
16. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
17. Dugo L., Collin M., Allen D.A., Murch O., Foster S.J., Yaqoob M.M., Thiemermann C. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition. Crit. Care Med. 2006, 34:1489-1496.
18. Van den Berghe G. Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?. Crit. Care 2010, 14:122.
19. Kapoor A., Shintani Y., Collino M., Osuchowski M.F., Busch D., Patel N.S., Sepodes B., Castiglia S., Fantozzi R., Bishop-Bailey D., Mota-Filipe H., Yaqoob M.M., Suzuki K., Bahrami S., Desvergne B., Mitchell J.A., Thiemermann C. Protective role of peroxisome proliferator-activated receptor-beta/delta in septic shock. Am. J. Respir. Crit. Care Med. 2010, 182:1506-1515.
20. Dugo L., Collin M., Thiemermann C. Glycogen synthase kinase-3 beta as a target for the therapy of shock and inflammation. Shock 2007, 27:113-123.
21. Zhao P., Turdi S., Dong F., Xiao X.Y., Su G.H., Zhu X.L., Scott G.I., Ren J. Cardiac-specific overexpression of insulin-like growth Factor I (Igf-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 2009, 32:100-107.
22. Peng T.Q., Lu X.R., Feng Q.P. Pivotal role of gp91(phox)-containing NADH oxidase in lipopolysaccharide-induced tumor necrosis factor-alpha expression and myocardial depression. Circulation 2005, 111:1637-1644.
23. Dong F., Li Q., Sreejayan N., Nunn J.M., Ren J. Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes 2007, 56:2201-2212.
24. Jiang S., Guo R., Zhang Y., Zou Y., Ren J. Heavy metal scavenger metallothionein mitigates deep hypothermia-induced myocardial contractile anomalies: role of autophagy. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E74-E86.
25. Ren J. Attenuated cardiac contractile responsiveness to insulin-like growth factor I in ventricular myocytes from biobreeding spontaneous diabetic rats. Cardiovasc. Res. 2000, 46:162-171.
26. Ceylan-Isik A.F., Zhao P., Zhang B.F., Mao X.Y., Su G.H., Ren J. Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J. Mol. Cell. Cardiol. 2010, 48:367-378.
27. Ren J., Privratsky J.R., Yang X.P., Dong F., Carlson E.C. Metallothionein alleviates glutathione depletion-induced oxidative caydiomyopathy in murine hearts. Crit. Care Med. 2008, 36:2106-2116.
28. Wang J., Chen L., Li D., Yin Y., Wang X., Li P., Dangott L.J., Hu W., Wu G. Intrauterine growth restriction affects the proteomes of the small intestine, liver, and skeletal muscle in newborn pigs. J. Nutr. 2008, 138:60-66.
29. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., Ogawa W., del Monte F., Gwathmey J.K., Grazette L., Hemmings B., Kass D.A., Champion H.C., Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 2005, 115:2128-2138.
30. Haq S., Choukroun G., Lim H., Tymitz K.M., del Monte F., Gwathmey J., Grazette L., Michael A., Hajjar R., Force T., Molkentin J.D. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 2001, 103:670-677.
31. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., Russo M.A., Gu Y.S., Dalton N., Chung C., Latronico M.V.G., Napoli C., Sadoshima J., Croce C.M., Ross J. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:12333-12338.
32. Sundaresan N.R., Pillai V.B., Wolfgeher D., Samant S., Vasudevan P., Parekh V., Raghuraman H., Cunningham J.M., Gupta M., Gupta M.P. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci. Signal. 2011, 4.
33. Hua Y.N., Zhang Y.M., Ceylan-Isik A.F., Wold L.E., Nunn J.M., Ren J. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic Res. Cardiol. 2011, 106:1173-1191.
34. Ali A., Hoeflich K.P., Woodgett J.R. Glycogen synthase kinase-3: properties, functions, and regulation. Chem. Rev. 2001, 101:2527-2540.
35. Kaidanovich-Beilin O., Woodgett J.R. GSK-3: functional insights from cell biology and animal models. Front. Mol. Neurosci. 2011, 4:40.
36. Wang H., Brown J., Martin M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 2011, 53:130-140.
37. Collino M., Aragno M., Castiglia S., Tomasinelli C., Thiemermann C., Boccuzzi G., Fantozzi R. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes 2009, 58:235-242.
38. Li C., Hua F., Ha T., Singh K., Lu C., Kalbfleisch J., Breuel K.F., Ford T., Kao R.L., Gao M., Ozment T.R., Williams D.L. Activation of myocardial phosphoinositide-3-kinase p110alpha ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis. PLoS One 2012, 7:e44712.
39. Rhee S.H., Kim H., Moyer M.P., Pothoulakis C. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. J. Biol. Chem. 2006, 281:18560-18568.
40. Fukao T., Yamada T., Tanabe M., Terauchi Y., Ota T., Takayama T., Asano T., Takeuchi T., Kadowaki T., Hata J., Koyasu S. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 2002, 3:295-304.
41. Li X.W., Tupper J.C., Bannerman D.D., Winn R.K., Rhodes C.J., Harlan J.M. Phosphoinositide 3 kinase mediates toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect. Immun. 2003, 71:4414-4420.
42. You W.J., Min X.Y., Zhang X.J., Qian B., Pang S.S., Ding Z.N., Li C.F., Gao X., Di R.M., Cheng Y.L., Liu L. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a Pi3k/Akt-dependent mechanism. Shock 2009, 32:108-117.
43. Veres B., Gallyas F., Varbiro G., Berente Z., Osz E., Szekeres G., Szabo C., Sumegi B. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem. Pharmacol. 2003, 65:1373-1382.
44. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 2002, 277:32124-32132.
45. Yu Y.M., Nagai S., Wu H.X., Neish A.S., Koyasu S., Gewirtz A.T. TLR5-mediated phosphoinositide 3-kinase activation negatively regulates flagellin-induced proinflammatory gene expression. J. Immunol. 2006, 176:6194-6201.
46. Zhou Z., Gengaro P., Wang W., Wang X.Q., Li C., Faubel S., Rivard C., Schrier R.W. Role of NF-kappaB and PI 3-kinase/Akt in TNF-alpha-induced cytotoxicity in microvascular endothelial cells. Am. J. Physiol. Renal Physiol. 2008, 295:F932-F941.
47. Bujak M., Frangogiannis N.G. The role of IL-1 in the pathogenesis of heart disease. Arch. Immunol. Ther. Exp. 2009, 57:165-176.
48. Gullestad L., Ueland T., Vinge L.E., Finsen A., Yndestad A., Aukrust P. Inflammatory cytokines in heart failure: mediators and markers. Cardiology 2012, 122:23-35.
49. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8:519-529.
50. Groenendyk J., Sreenivasaiah P.K., Kim do H., Agellon L.B., Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ. Res. 2010, 107:1185-1197.
51. Lindholm D., Wootz H., Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006, 13:385-392.
52. Ron D. Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J. Clin. Invest. 2002, 109:443-445.
53. Laybutt D.R., Preston A.M., Akerfeldt M.C., Kench J.G., Busch A.K., Biankin A.V., Biden T.J. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007, 50:752-763.
54. Dickhout J.G., Carlisle R.E., Austin R.C. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease endoplasmic reticulum stress as a mediator of pathogenesis. Circ. Res. 2011, 108:629-642.
55. Endo M., Oyadomari S., Suga M., Mori M., Gotoh T. The ER stress pathway involving CHOP is activated in the lungs of LPS-treated mice. J. Biochem. 2005, 138:501-507.
56. Maulik S.K., Kumar S. Oxidative stress and cardiac hypertrophy: a review. Toxicol. Mech. Methods 2012, 22:359-366.
57. Andrades M.E., Ritter C., Dal-Pizzol F. The role of free radicals in sepsis development. Front. Biosci. (Elite Ed.) 2009, 1:277-287.
58. Fadeel B., Orrenius S., Zhivotovsky B. The potential role of apoptosis in human disease. Med. Princ. Pract. 2000, 9:151-163.
59. Haunstetter A., Izumo S. Apoptosis - basic mechanisms and implications for cardiovascular disease. Circ. Res. 1998, 82:1111-1129.
60. White S.J., Phil D., Newby A.C. Gene therapy for all aspects of vein-graft disease. J. Card. Surg. 2002, 17:549-555.
61. Carlson D.L., Willis M.S., White D.J., Horton J.W., Giroir B.P. Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit. Care Med. 2005, 33:1021-1028.
62. McDonald T.E., Grinman M.N., Carthy C.M., Walley K.R. Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2053-H2061.
63. Sugden P.H., Clerk A. Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxid. Redox Signal. 2006, 8:2111-2124.
64. Bommhardt U., Chang K.C., Swanson P.E., Wagner T.H., Tinsley K.W., Karl I.E., Hotchkiss R.S. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 2004, 172:7583-7591.
65. Monick M.M., Mallampalli R.K., Carter A.B., Flaherty D.M., McCoy D., Robeff P.K., Peterson M.W., Hunninghake G.W. Ceramide regulates lipopolysaccharide-induced phosphatidylinositol 3-kinase and Akt activity in human alveolar macrophages. J. Immunol. 2001, 167:5977-5985.
66. Xu X., Ren J. Unmasking the janus faces of autophagy in obesity-associated insulin resistance and cardiac dysfunction. Clin. Exp. Pharmacol. Physiol. 2012, 39:200-208.
67. Tanida I. Autophagy basics. Microbiol. Immunol. 2011, 55:1-11.
68. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ. Res. 2009, 104:150-158.
69. McCormick J., Knight R.A., Barry S.P., Scarabelli T.M., Abounit K., Latchman D.S., Stephanou A. Autophagy in the stress-induced myocardium. Front. Biosci. (Elite Ed.) 2012, 4:2131-2141.
70. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., Yang G., Matsui Y., Sadoshima J., Vatner S.F. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13807-13812.
71. Zhang D., Contu R., Latronico M.V., Zhang J., Rizzi R., Catalucci D., Miyamoto S., Huang K., Ceci M., Gu Y., Dalton N.D., Peterson K.L., Guan K.L., Brown J.H., Chen J., Sonenberg N., Condorelli G. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 2010, 120:2805-2816.
72. Rothermel B.A., Hill J.A. Autophagy in load-induced heart disease. Circ. Res. 2008, 103:1363-1369.
73. Hsieh C.H., Pai P.Y., Hsueh H.W., Yuan S.S., Hsieh Y.C. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann. Surg. 2011, 253:1190-1200.
74. Dutta D., Calvani R., Bernabei R., Leeuwenburgh C., Marzetti E. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ. Res. 2012, 110:1125-1138.
75. Yang Z., Klionsky D.J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 2009, 335:1-32.
76. Seibenhener M.L., Geetha T., Wooten M.W. Sequestosome 1/p62-more than just a scaffold. FEBS Lett. 2007, 581:175-179.
77. Moscat J., Diaz-Meco M.T., Wooten M.W. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 2007, 32:95-100.
78. Doi K., Leelahavanichkul A., Yuen P.S., Star R.A. Animal models of sepsis and sepsis-induced kidney injury. J. Clin. Invest. 2009, 119:2868-2878.